Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-14 Sale(A) | 2026-07-17 7:12 pm | Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner | 28,315 | $37.54 | $1,063,033 | 40,000 (Indirect) | View |
| 2026-07-14 Sale | 2026-07-16 5:14 pm | Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner | 28,315 | $37.54 | $1,063,033 | 40,000 (Indirect) | View |
| 2026-07-02 Sale | 2026-07-07 6:29 pm | Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner | 126,685 | $37.64 | $4,768,637 | 53,315 (Indirect) | View |
| 2026-06-17 Sale | 2026-06-17 5:08 pm | Eton Pharmaceuticals Inc. | ETON | Adams Jennifer McKie Director | 50,000 | $32.48 | $1,623,795 | 0 (Direct) | View |
| 2026-05-28 Sale | 2026-05-29 4:16 pm | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 120,000 | $31.88 | $3,825,717 | 833,694 (Direct) | View |
| 2026-05-22 Sale | 2026-05-27 6:28 pm | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 100,000 | $32.3 | $3,229,923 | 281,740 (Direct) | View |
| 2025-08-19 Sale | 2025-08-20 5:14 pm | Eton Pharmaceuticals Inc. | ETON | Gruber James R. Chief Financial Officer | 41,713 | $16.15 | $673,714 | 204,753 (Direct) | View |
| 2025-06-12 Sale | 2025-06-16 4:56 pm | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 34,000 | $14.83 | $504,318 | 612,646 (Direct) | View |
| 2025-06-10 Purchase | 2025-06-12 4:32 pm | Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner | 7,930 | $15.82 | $125,484 | 85,000 (Indirect) | View |
| 2025-06-03 Sale | 2025-06-05 5:15 pm | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO 10% Owner | 210,000 | $17.11 | $3,592,611 | 2,873,513 (Direct) | View |
| 2024-10-23 Purchase | 2024-10-25 4:05 pm | Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner | 10,000 | $7.9814 | $79,814 | 2,770,000 (Indirect) | View |
| 2024-10-04 Purchase | 2024-10-08 6:34 pm | Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner | 62,070 | $6.9943 | $434,137 | 82,070 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-12 Exercise | 2026-07-14 5:28 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 227,500 | $0 | 1,061,194 (Direct) | View |
| 2026-07-14 Exercise | 2026-07-14 5:28 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 200,000 | $1.37 | 1,061,194 (Direct) | View |
| 2026-07-12 Exercise | 2026-07-13 4:36 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 10,000 | $0 | 37,025 (Direct) | View |
| 2026-06-26 Option Award | 2026-06-30 4:27 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 10,000 | $0 | 96,829 (Direct) | View |
| 2026-06-17 Exercise | 2026-06-17 5:08 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Adams Jennifer McKie Director | 50,000 | $3.78 | 0 (Direct) | View |
| 2026-06-17 Exercise | 2026-06-17 5:08 pm | 2023-02-07 2032-02-06 | Eton Pharmaceuticals Inc. | ETON | Adams Jennifer McKie Director | 50,000 | $0 | 0 (Direct) | View |
Ownership | 2026-06-01 4:26 pm | N/A 2036-04-12 | Eton Pharmaceuticals Inc. | ETON | Matthews Judith M. Chief Financial Officer | 0 | $0 | 37,000 (Direct) | View |
| 2026-05-22 Exercise | 2026-05-27 6:28 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 37,794 | $3.58 | 281,740 (Direct) | View |
| 2026-05-22 Exercise | 2026-05-27 6:28 pm | 2020-03-12 2030-03-11 | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 87,794 | $0 | 281,740 (Direct) | View |
| 2026-05-26 Exercise | 2026-05-27 6:28 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 25,000 | $1.37 | 281,740 (Direct) | View |
| 2026-05-26 Exercise | 2026-05-27 6:28 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 25,000 | $1.38 | 281,740 (Direct) | View |
| 2026-04-21 Exercise | 2026-04-22 4:40 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 19,655 | $8.61 | 224,300 (Direct) | View |
| 2026-04-21 Exercise | 2026-04-22 4:40 pm | 2020-02-20 2029-02-19 | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 32,155 | $0 | 224,300 (Direct) | View |
| 2026-04-21 Exercise | 2026-04-22 4:40 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 12,500 | $7.31 | 224,300 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-05 5:18 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 30,000 | $4.42 | 192,145 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-05 5:18 pm | 2025-02-13 2034-02-12 | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 30,000 | $0 | 192,145 (Direct) | View |
| 2026-01-12 Option Award | 2026-01-14 6:09 pm | N/A 2036-01-11 | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 19,953 | $0 | 580,749 (Direct) | View |
| 2026-01-12 Option Award | 2026-01-14 6:08 pm | N/A 2036-01-11 | Eton Pharmaceuticals Inc. | ETON | Adams Jennifer McKie Director | 19,953 | $0 | 348,415 (Direct) | View |
| 2026-01-12 Option Award | 2026-01-14 6:07 pm | N/A 2036-01-11 | Eton Pharmaceuticals Inc. | ETON | CASAMENTO CHARLES J Director | 19,953 | $0 | 598,099 (Direct) | View |
| 2026-01-12 Option Award | 2026-01-14 6:06 pm | N/A 2036-01-11 | Eton Pharmaceuticals Inc. | ETON | MAIER PAUL V Director | 19,953 | $0 | 580,749 (Direct) | View |
| 2026-01-12 Option Award | 2026-01-14 6:05 pm | N/A 2036-01-11 | Eton Pharmaceuticals Inc. | ETON | Erdogan-Trinkaus Ipek Chief Commercial Officer | 66,511 | $0 | 273,612 (Direct) | View |
| 2026-01-12 Option Award | 2026-01-14 6:04 pm | N/A 2036-01-11 | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO 10% Owner | 258,563 | $0 | 9,084,407 (Direct) | View |
| 2026-01-01 Tax Withholding | 2026-01-14 6:04 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO 10% Owner | 5,015 | $15.39 | 9,084,407 (Direct) | View |
| 2026-01-14 Tax Withholding | 2026-01-14 6:03 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 1,942 | $15.62 | 1,997,880 (Direct) | View |
| 2026-01-12 Option Award | 2026-01-14 6:03 pm | N/A 2036-01-11 | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 66,511 | $0 | 1,997,880 (Direct) | View |
| 2026-01-12 Option Award | 2026-01-14 6:02 pm | N/A 2036-01-11 | Eton Pharmaceuticals Inc. | ETON | Gruber James R. Chief Financial Officer | 66,511 | $0 | 747,426 (Direct) | View |
| 2026-01-14 Tax Withholding | 2026-01-14 6:02 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Gruber James R. Chief Financial Officer | 2,293 | $15.47 | 747,426 (Direct) | View |
| 2025-12-12 Tax Withholding | 2025-12-12 4:57 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Erdogan-Trinkaus Ipek Chief Commercial Officer | 85 | $16.9 | 2,403 (Direct) | View |
| 2025-12-11 Option Award | 2025-12-12 4:56 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 5,300 | $0 | 1,270,648 (Direct) | View |
| 2025-12-12 Tax Withholding | 2025-12-12 4:56 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 6,264 | $17 | 1,270,648 (Direct) | View |
| 2025-12-11 Option Award | 2025-12-12 4:55 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Gruber James R. Chief Financial Officer | 5,502 | $0 | 425,968 (Direct) | View |
| 2025-12-12 Tax Withholding | 2025-12-12 4:55 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Gruber James R. Chief Financial Officer | 4,542 | $16.99 | 425,968 (Direct) | View |
| 2025-12-12 Tax Withholding | 2025-12-12 4:54 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO 10% Owner | 6,732 | $16.83 | 2,894,281 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-06 4:23 pm | N/A 2035-01-02 | Eton Pharmaceuticals Inc. | ETON | Adams Jennifer McKie Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-01-03 Exercise | 2025-01-06 4:22 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 50,000 | $3.78 | 162,145 (Direct) | View |
| 2025-01-03 Exercise | 2025-01-06 4:22 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 25,000 | $3.47 | 162,145 (Direct) | View |
| 2025-01-03 Exercise | 2025-01-06 4:22 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 27,400 | $3.58 | 162,145 (Direct) | View |
| 2025-01-03 Exercise | 2025-01-06 4:22 pm | 2021-03-12 2030-03-12 | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 102,400 | $0 | 162,145 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-06 4:21 pm | N/A 2035-01-02 | Eton Pharmaceuticals Inc. | ETON | CASAMENTO CHARLES J Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-06 4:20 pm | N/A 2035-01-02 | Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-06 4:18 pm | N/A 2035-01-02 | Eton Pharmaceuticals Inc. | ETON | MAIER PAUL V Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-06 4:18 pm | N/A 2035-01-02 | Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO | 179,473 | $0 | 179,473 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-06 4:16 pm | N/A 2035-01-02 | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 64,497 | $0 | 64,497 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-06 4:15 pm | N/A 2035-01-02 | Eton Pharmaceuticals Inc. | ETON | Gruber James R. Chief Financial Officer | 64,497 | $0 | 64,497 (Direct) | View |
Ownership | 2024-12-09 5:11 pm | N/A 2027-12-01 | Eton Pharmaceuticals Inc. | ETON | Erdogan-Trinkaus Ipek Chief Commercial Officer | 0 | $0 | 83,026 (Direct) | View |
| 2024-10-02 Option Award | 2024-10-04 4:19 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Krempa David Chief Business Officer | 42,088 | $0 | 861,374 (Direct) | View |